Literature DB >> 2433708

Studies on the possible role of brain 5-HT systems and adrenocortical activity in behavioural responses to nicotine and diazepam in an elevated X-maze.

D J Balfour, C A Graham, A L Vale.   

Abstract

Subchronic (6 days) but not acute injections of nicotine (0.4 mg/kg SC) increased spontaneous activity (P less than 0.01) in an elevated X-maze composed of two open and two enclosed runways. Neither acute nor subchronic nicotine altered significantly the ratio of open:enclosed runway entries (O/E ratio). Diazepam (5 mg/kg PO) had no significant effects on spontaneous activity but increased the O/E ratio (P less than 0.05). Acute nicotine increased (P less than 0.01) whereas subchronic nicotine caused a small decrease (P less than 0.05) in the plasma corticosterone concentration. Both acute and subchronic diazepam decreased the levels of the hormone (P less than 0.01 and P less than 0.05, respectively) although the reduction elicited by chronic diazepam was less than that caused by acute diazepam (P less than 0.05). In the experiments with diazepam the plasma corticosterone concentration correlated negatively with the O/E ratio (r = -0.58; P less than 0.05), whereas in the experiments with nicotine plasma corticosterone correlated negatively (r = -0.46; P less than 0.05) with enclosed runway entries. Nicotine injections were associated with a regionally-selective reduction in the 5-hydroxyindole acetic acid (5-HIAA) concentration in the hippocampus (P less than 0.05) and a reduction in hippocampal 5-hydroxytryptamine (5-HT) which approached statistical significance. Chronic, but not acute, diazepam increased (P less than 0.01) hypothalamic 5-HT. The changes in 5-HT and 5-HIAA did not appear to be directly related to the behavioural or adrenocortical responses to either of the drugs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2433708     DOI: 10.1007/bf00174073

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma.

Authors:  D MATTINGLY
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

2.  Acute and chronic tolerance to nicotine measured by activity in rats.

Authors:  I P Stolerman; R Fink; M E Jarvik
Journal:  Psychopharmacologia       Date:  1973-06-29

3.  Drug effects on a measure of unconditioned avoidance in the rat.

Authors:  C F Morrison; J A Stephenson
Journal:  Psychopharmacologia       Date:  1970

4.  A simple, sensitive and reliable assay for serotonin and 5-HIAA in brain tissue using liquid chromatography with electrochemical detection.

Authors:  J F Reinhard; M A Moskowitz; A F Sved; J D Fernstrom
Journal:  Life Sci       Date:  1980-09-15       Impact factor: 5.037

5.  Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles.

Authors:  M E Benwell; D J Balfour
Journal:  Psychopharmacology (Berl)       Date:  1979-05-08       Impact factor: 4.530

6.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

7.  Relationships between plasma corticosteroids and benzodiazepines in stress.

Authors:  G Le Fur; F Guilloux; N Mitrani; J Mizoule; A Uzan
Journal:  J Pharmacol Exp Ther       Date:  1979-11       Impact factor: 4.030

8.  Plasma corticosterone and brain catecholamines in stress: effect of psychotropic drugs.

Authors:  K L Keim; E B Sigg
Journal:  Pharmacol Biochem Behav       Date:  1977-01       Impact factor: 3.533

9.  The effects of nicotine administration on 5-HT uptake and biosynthesis in rat brain.

Authors:  M E Benwell; D J Balfour
Journal:  Eur J Pharmacol       Date:  1982-10-15       Impact factor: 4.432

10.  Reduction of nicotine-induced hyperactivity by pCPA.

Authors:  R E Fitzgerald; R Oettinger; K Bättig
Journal:  Pharmacol Biochem Behav       Date:  1985-08       Impact factor: 3.533

View more
  7 in total

1.  Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.

Authors:  Sean P David; Elaine C Johnstone; Michael F G Murphy; Paul Aveyard; Boliang Guo; Caryn Lerman; Marcus R Munafò
Journal:  Drug Alcohol Depend       Date:  2008-06-17       Impact factor: 4.492

Review 2.  Anxiogenic properties of beta-CCE and FG 7142: a review of promises and pitfalls.

Authors:  M H Thiébot; P Soubrié; D Sanger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Studies on the influence of nicotine infusions on mesolimbic dopamine and locomotor responses to nicotine.

Authors:  M E Benwell; D J Balfour; L F Khadra
Journal:  Clin Investig       Date:  1994-02

4.  Smoking-associated changes in the serotonergic systems of discrete regions of human brain.

Authors:  M E Benwell; D J Balfour; J M Anderson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock.

Authors:  J Itoh; T Nabeshima; T Kameyama
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Opposing effects of acute and repeated nicotine exposure on boldness in zebrafish.

Authors:  Rachel Dean; Erika Duperreault; Dustin Newton; Jeffrey Krook; Erica Ingraham; Joshua Gallup; Brian C Franczak; Trevor J Hamilton
Journal:  Sci Rep       Date:  2020-05-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.